er logo points to home page Home page Search Glossary Search Links Database Sitemap Contact Expert Reviews in Molecular Medicine
          Register interest

Expert Reviews in Molecular Medicine: http://www.expertreviews.org/
DOI: 10.1017/S1462399407000488; 2 November 2007
Anne M. Dickinson, Jane L. Harrold and Hannah Cullup (2007) Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev. Mol. Med. Vol. 9, Issue 29, DOI: 10.1017/S1462399407000488

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?

Anne M. Dickinson a1 c1, Jane L. Harrold a1 and Hannah Cullup a1

a1 School of Clinical and Laboratory Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK.

c1 Corresponding author: Anne Dickinson, Institute of Cellular Medicine, School of Clinical and Laboratory Sciences, Newcastle upon Tyne, NE2 4HH, UK. Tel/Fax: +44 (0)191 222 6794; E-mail: a.m.dickinson@ncl.ac.uk

Haematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for many patients with malignant and non-malignant haematological diseases. The success of HSCT is greatly reduced by the development of complications, which include graft-versus-host disease (GVHD), relapse and infection. Human leukocyte antigen (HLA) matching of patients and donors is essential, but does not completely prevent these complications; non-HLA genes may also have an impact upon transplant outcome. Polymorphisms within genes that are associated with an individual's capability to mount an immune response to alloantigen and infectious pathogens and/or response to drugs (pharmacogenomics) are all currently being studied for their association with HSCT outcome. This review summarises the potential role of non-HLA polymorphisms in predicting HSCT outcome, from studies on retrospective transplant cohorts of HLA-identical siblings and matched unrelated donors. The clinical relevance and interpretation of non-HLA genetics, and how these could be used alongside clinical risk factors in HSCT, are also discussed.

Full text online (purchase or subscribe through Cambridge Journals Online)

| home | search | glossary | links | sitemap | contact |

Expert Reviews in Molecular Medicine © Cambridge University Press ISSN 1462-3994 (Disclaimer and copyright)
Editorial Office: Centre for Applied Research in Educational Technologies (CARET), 1st Floor, 16 Mill Lane, Cambridge, CB2 1SB, UK. Tel: +44 (0)1223 765 375; Fax: +44(0)1223 765 505; E-mail: ermm@caret.cam.ac.uk